Both in Pharmaceuticals
Oragenics vs Sunshine Biopharma
Over the past year OGEN returned −70.8% and SBFM returned −99.2%; their daily moves had a correlation of 0.09.
OGEN −70.8% SBFM −99.2%Growth of $1, one year, split-adjusted
| Metric | OGEN | SBFM |
|---|---|---|
| Price | $0.3800 | $3.11 |
| Market cap | $1.7M | $2.3M |
| Today | +3.83% | +5.07% |
| 1 month | −20.8% | −80.3% |
| 6 months | −37.1% | −98.4% |
| Year to date | −51.5% | −98.7% |
| 1 year | −71.4% | −99.2% |
| Revenue growth (YoY) | — | −1.6% |
| Gross margin | — | 26.2% |
| Net margin | — | −16.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.1× |
| Net cash | $3.9M | $13.7M |
| Dividend yield | — | — |
| Volatility (60d) | 50.5% | 896.4% |
| Short % of float | 24.4% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).